Search
Close this search box.

Blog

The GAfPA Policy Blog explores health policy news, reports, initiatives and events that inform patient-centered care.

Blog Posts

Not all patients have enough information to protect themselves from preventable heart attacks and strokes, a newly released questionnaire of European patients confirms. The finding offers insight into cardiovascular disease in Europe, which claims more than 4 million lives each year.
Development of biosimilars has expanded patients’ treatment options by offering innovative medicine at lower costs than traditional biologics. So why are some nations slow to adopt biosimilars? In many instances it boils down to unfamiliarity with the approval process, leading to distrust.